We invented, developed and now hold the worldwide rights to MTI-12 technology – for a broad spectrum of aesthetic and therapeutic indications; and as well as the technology behind our CYTOSIAL cross-linked hyaluronic acid dermal filler range, and its use in other indications.

We aim to leverage our biotechnology and aesthetic expertise to expand our product line up and to serv the interests of our stakeholders; Bioxis is the dynamic company you’ve been searching for. Now’s your chance – don’t miss out.

Get Involved

Bioxis Pharmaceuticals is incorporated under the laws of France with headquarters located at
317 avenue Jean Jaures, 69007 Lyon, France.